{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:19:36Z","timestamp":1773364776326,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fundacja Rozwoju Nauki w Wojew\u00f3dzkim Szpitalu Zaka\u017anym"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10157-018-1644-5","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T06:55:24Z","timestamp":1536908124000},"page":"342-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk factors for kidney disease among HIV-1 positive persons in the methadone program"],"prefix":"10.1007","volume":"23","author":[{"given":"Bart\u0142omiej","family":"Mat\u0142osz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Pietraszkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Firl\u0105g-Burkacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Grycner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Horban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna D.","family":"Kowalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"issue":"9","key":"1644_CR1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.4065\/82.9.1103","volume":"82","author":"TI Silva de","year":"2007","unstructured":"Silva TI de, Post FA, Griffin MD, et al. HIV-1 infection and the kidney: an evolving challenge in HIV medicine. Mayo Clin Proc. 2007;82(9):1103\u201316. \n                    https:\/\/doi.org\/10.4065\/82.9.1103\n                    \n                  .","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"1644_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1468-1293.2008.00691.x","volume":"10","author":"LJ Campbell","year":"2009","unstructured":"Campbell LJ, Ibrahim F, Fisher M, et al. Spectrum of chronic kidney disease in HIV-infected patients. HIV Med. 2009;10(6):329\u201336. \n                    https:\/\/doi.org\/10.1111\/j.1468-1293.2008.00691.x\n                    \n                  .","journal-title":"HIV Med"},{"issue":"2","key":"1644_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/MAJ.0b013e31812e6b34","volume":"335","author":"SK Fernando","year":"2008","unstructured":"Fernando SK, Finkelstein FO, Moore BA, et al. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci. 2008;335(2):89\u201394. \n                    https:\/\/doi.org\/10.1097\/MAJ.0b013e31812e6b34\n                    \n                  .","journal-title":"Am J Med Sci"},{"issue":"9","key":"1644_CR4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/QAD.0b013e3280f774ee","volume":"21","author":"A Mocroft","year":"2007","unstructured":"Mocroft A, Kirk O, Gatell J, et al. Chronic renal failure among HIV-1-infected patients. AIDS. 2007;21(9):1119\u201327. \n                    https:\/\/doi.org\/10.1097\/QAD.0b013e3280f774ee\n                    \n                  .","journal-title":"AIDS"},{"issue":"2","key":"1644_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1086\/589296","volume":"47","author":"J Roe","year":"2008","unstructured":"Roe J, Campbell LJ, Ibrahim F, et al. HIV care and the incidence of acute renal failure. Clin Infect Dis. 2008;47(2):242\u20139. \n                    https:\/\/doi.org\/10.1086\/589296\n                    \n                  .","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1644_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/QAI.0b013e31817bbecb","volume":"48","author":"ML Sorli","year":"2008","unstructured":"Sorli ML, Guelar A, Montero M, et al. Chronic kidney disease prevalence and risk factors among HIV-infected patients. J Acquir Immune Defic Syndr. 2008;48(4):506\u20138. \n                    https:\/\/doi.org\/10.1097\/QAI.0b013e31817bbecb\n                    \n                  .","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"15","key":"1644_CR7","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1097\/QAD.0b013e3282ef1bb4","volume":"21","author":"CM Wyatt","year":"2007","unstructured":"Wyatt CM, Winston JA, Malvestutto CD, et al. Chronic kidney disease in HIV infection: an urban epidemic. AIDS. 2007;21(15):2101\u20133. \n                    https:\/\/doi.org\/10.1097\/QAD.0b013e3282ef1bb4\n                    \n                  .","journal-title":"AIDS"},{"issue":"10","key":"1644_CR8","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ndt\/gfv207","volume":"30","author":"S Razzak Chaudhary","year":"2015","unstructured":"Razzak Chaudhary S, Workeneh BT, Montez-Rath ME, et al. Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy. Nephrol Dial Transplant. 2015;30(10):1734\u201340. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfv207\n                    \n                  .","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"1644_CR9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/infdis\/jit043","volume":"207","author":"L Ryom","year":"2013","unstructured":"Ryom L, Mocroft A, Kirk O, et al. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. J Infect Dis. 2013;207(9):1359\u201369. \n                    https:\/\/doi.org\/10.1093\/infdis\/jit043\n                    \n                  .","journal-title":"J Infect Dis"},{"issue":"5","key":"1644_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/QAD.0000000000000103","volume":"28","author":"JC Yombi","year":"2014","unstructured":"Yombi JC, Pozniak A, Boffito M, et al. Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity. AIDS. 2014;28(5):621\u201332. \n                    https:\/\/doi.org\/10.1097\/QAD.0000000000000103\n                    \n                  .","journal-title":"AIDS"},{"issue":"1","key":"1644_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.07.014","volume":"106","author":"S Darke","year":"2010","unstructured":"Darke S, Duflou J, Torok M. The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases. Drug Alcohol Depend. 2010;106(1):1\u20136. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.07.014\n                    \n                  .","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1644_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2215\/CJN.00300106","volume":"1","author":"JA Jaffe","year":"2006","unstructured":"Jaffe JA, Kimmel PL. Chronic nephropathies of cocaine and heroin abuse: a critical review. Clin J Am Soc Nephrol. 2006;1(4):655\u201367. \n                    https:\/\/doi.org\/10.2215\/CJN.00300106\n                    \n                  .","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1644_CR13","first-page":"373","volume":"45","author":"W Szata","year":"1991","unstructured":"Szata W. Changes in the epidemiological situation of HIV infections and AIDS in Poland 1985\u20131991 and resulting directions of necessary actions (Zmiany sytuacji epidemiologicznej zakazen HIV i zachorowan na AIDS w Polsce w latach 1985\u20131991 oraz wynikajace z nich kierunki niezbednych dzialan). Przegl Epidemiol. 1991;45(4):373\u20136.","journal-title":"Przegl Epidemiol"},{"issue":"2","key":"1644_CR14","first-page":"249","volume":"70","author":"M Niedzwiedzka-Stadnik","year":"2016","unstructured":"Niedzwiedzka-Stadnik M, Pielacha M, Rosinska M. HIV and AIDS in Poland in 2014. Przegl Epidemiol. 2016;70(2):249\u201359.","journal-title":"Przegl Epidemiol"},{"issue":"11","key":"1644_CR15","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.2215\/CJN.00360114","volume":"9","author":"WF3 Pendergraft","year":"2014","unstructured":"Pendergraft WF3, Herlitz LC, Thornley-Brown D, et al. Nephrotoxic effects of common and emerging drugs of abuse. Clin J Am Soc Nephrol. 2014;9(11):1996\u20132005. \n                    https:\/\/doi.org\/10.2215\/CJN.00360114\n                    \n                  .","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1644_CR16","first-page":"437","volume":"26","author":"MY Daud","year":"2014","unstructured":"Daud MY, Qazi RA, Bashir N. Anti-retroviral drugs compliance in intravenous and non intravenous drug abusers. J Ayub Med Coll Abbottabad. 2014;26(4):437\u201340.","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"1","key":"1644_CR17","first-page":"58","volume":"8","author":"RC Freeman","year":"1996","unstructured":"Freeman RC, Rodriguez GM, French JF. Compliance with AZT treatment regimen of HIV-seropositive injection drug users: a neglected issue. AIDS Educ Prev. 1996;8(1):58\u201371.","journal-title":"AIDS Educ Prev"},{"issue":"13","key":"1644_CR18","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1097\/00002030-199909100-00021","volume":"13","author":"V Gordillo","year":"1999","unstructured":"Gordillo V, del Amo J, Soriano V, et al. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13(13):1763\u20139.","journal-title":"AIDS"},{"issue":"1","key":"1644_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1023\/A:1022513507669","volume":"7","author":"RH Remien","year":"2003","unstructured":"Remien RH, Hirky AE, Johnson MO, et al. Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities. AIDS Behav. 2003;7(1):61\u201372.","journal-title":"AIDS Behav"},{"issue":"3","key":"1644_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/09540129650125696","volume":"8","author":"N Singh","year":"1996","unstructured":"Singh N, Squier C, Sivek C, et al. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8(3):261\u20139. \n                    https:\/\/doi.org\/10.1080\/09540129650125696\n                    \n                  .","journal-title":"AIDS Care"},{"key":"1644_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12981-015-0084-5","volume":"13","author":"JD Kowalska","year":"2016","unstructured":"Kowalska JD, Kubicka J, Siwak E, et al. Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients. AIDS Res Ther. 2016;13:2. \n                    https:\/\/doi.org\/10.1186\/s12981-015-0084-5\n                    \n                  .","journal-title":"AIDS Res Ther"},{"issue":"1","key":"1644_CR22","first-page":"5","volume":"Suppl. 3","author":"K","year":"2013","unstructured":"KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;Suppl. 3(1):5\u2013119.","journal-title":"Kidney Int"},{"key":"1644_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cobeha.2016.09.007","volume":"13","author":"K Bachi","year":"2017","unstructured":"Bachi K, Sierra S, Volkow ND, et al. Is biological aging accelerated in drug addiction? Curr Opin Behav Sci. 2017;13:34\u20139. \n                    https:\/\/doi.org\/10.1016\/j.cobeha.2016.09.007\n                    \n                  .","journal-title":"Curr Opin Behav Sci"},{"issue":"2","key":"1644_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1440-1797.2011.01537.x","volume":"17","author":"L Berney-Meyer","year":"2012","unstructured":"Berney-Meyer L, Putt T, Schollum J, et al. Nephrotoxicity of recreational party drugs. Nephrology (Carlton). 2012;17(2):99\u2013103. \n                    https:\/\/doi.org\/10.1111\/j.1440-1797.2011.01537.x\n                    \n                  .","journal-title":"Nephrology (Carlton)"},{"issue":"10","key":"1644_CR25","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.2215\/CJN.01030210","volume":"5","author":"EL Yanik","year":"2010","unstructured":"Yanik EL, Lucas GM, Vlahov D, et al. HIV and proteinuria in an injection drug user population. Clin J Am Soc Nephrol. 2010;5(10):1836\u201343. \n                    https:\/\/doi.org\/10.2215\/CJN.01030210\n                    \n                  .","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1644_CR26","doi-asserted-by":"publisher","first-page":"765.e1","DOI":"10.1016\/j.ajem.2015.08.051","volume":"34","author":"JR Argamany","year":"2016","unstructured":"Argamany JR, Reveles KR, Duhon B. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure. Am J Emerg Med. 2016;34(4):765.e1\u20132. \n                    https:\/\/doi.org\/10.1016\/j.ajem.2015.08.051\n                    \n                  .","journal-title":"Am J Emerg Med"},{"issue":"8","key":"1644_CR27","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00204-012-0815-5","volume":"86","author":"M Carvalho","year":"2012","unstructured":"Carvalho M, Carmo H, Costa VM, et al. Toxicity of amphetamines: an update. Arch Toxicol. 2012;86(8):1167\u2013231. \n                    https:\/\/doi.org\/10.1007\/s00204-012-0815-5\n                    \n                  .","journal-title":"Arch Toxicol"},{"issue":"1","key":"1644_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/1319-2442.174195","volume":"27","author":"R Lamia","year":"2016","unstructured":"Lamia R, El Ati Z, Ben Fatma L, et al. Malignant hypertension-associated thrombotic microangiopathy following cocaine use. Saudi J Kidney Dis Transpl. 2016;27(1):153\u20136. \n                    https:\/\/doi.org\/10.4103\/1319-2442.174195\n                    \n                  .","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"5","key":"1644_CR29","doi-asserted-by":"publisher","first-page":"689","DOI":"10.5858\/arpa.2013-0075-CR","volume":"138","author":"S Porubsky","year":"2014","unstructured":"Porubsky S, Kuppe C, Maier T, et al. Renal lipidosis in patients enrolled in a methadone substitution program. Arch Pathol Lab Med. 2014;138(5):689\u201393. \n                    https:\/\/doi.org\/10.5858\/arpa.2013-0075-CR\n                    \n                  .","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"1644_CR30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3265\/Nefrologia.pre2011.Dec.11256","volume":"32","author":"F Valga-Amado","year":"2012","unstructured":"Valga-Amado F, Monzon-Vazquez TR, Hadad F, et al. Rhabdomyolysis with acute renal failure secondary to taking methadone. Nefrologia. 2012;32(2):262\u20133. \n                    https:\/\/doi.org\/10.3265\/Nefrologia.pre2011.Dec.11256\n                    \n                  .","journal-title":"Nefrologia"},{"issue":"7","key":"1644_CR31","doi-asserted-by":"publisher","first-page":"e41673","DOI":"10.1371\/journal.pone.0041673","volume":"7","author":"J Reekie","year":"2012","unstructured":"Reekie J, Kowalska JD, Karpov I, et al. Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study. PLoS One. 2012;7(7):e41673. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0041673\n                    \n                  .","journal-title":"PLoS One"},{"issue":"3","key":"1644_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/QAD.0b013e32834e8805","volume":"26","author":"JD Kowalska","year":"2012","unstructured":"Kowalska JD, Reekie J, Mocroft A, et al. Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy. AIDS. 2012;26(3):315\u201323. \n                    https:\/\/doi.org\/10.1097\/QAD.0b013e32834e8805\n                    \n                  .","journal-title":"AIDS"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-018-1644-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T23:22:16Z","timestamp":1568416936000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-018-1644-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1644"],"URL":"https:\/\/doi.org\/10.1007\/s10157-018-1644-5","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,14]]},"assertion":[{"value":"29 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number AKBE\/40\/17) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Due to study design (retrospective analysis of the electronic database) informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}